MDWD Price-to-Operating-Cash-Flow - GuruFocus.com
MDWD Stock | USD 17.15 0.02 0.12% |
About 55% of Mediwound's investor base is interested to short. The analysis of overall sentiment of trading Mediwound stock suggests that many investors are impartial at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
Mediwound |
MDWD Price-to-Operating-Cash-Flow GuruFocus.com
Read at news.google.com
Mediwound Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Mediwound Fundamental Analysis
We analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Mediwound is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Mediwound Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mediwound stock to make a market-neutral strategy. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics with similar companies.
Peers
Mediwound Related Equities
CRNX | Crinetics Pharmaceuticals | 5.21 | ||||
STRO | Sutro Biopharma | 4.26 | ||||
DYAI | Dyadic International | 3.77 | ||||
KROS | Keros Therapeutics | 3.59 | ||||
OCUL | Ocular Therapeutix | 1.27 | ||||
VCYT | Veracyte | 1.23 | ||||
INBX | Inhibrx | 1.00 | ||||
NKTX | Nkarta | 0.80 | ||||
MRUS | Merus BV | 0.58 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
FHTX | Foghorn Therapeutics | 1.28 | ||||
RNA | Avidity Biosciences | 1.44 | ||||
MLYS | Mineralys Therapeutics, | 1.45 | ||||
REPL | Replimune | 1.56 | ||||
GBIO | Generation Bio | 1.56 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
KRON | Kronos Bio | 2.86 | ||||
SWTX | SpringWorks Therapeutics | 4.52 | ||||
SNDX | Syndax Pharmaceuticals | 4.75 | ||||
SANA | Sana Biotechnology | 5.65 | ||||
LYEL | Lyell Immunopharma | 7.61 | ||||
GLUE | Monte Rosa | 9.85 |
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |